2022: Counterfeit and substandard drugs in Tanzania

In Post Marketing Surveillance (PMS) conducted by the government authority responsible for medicines, it shows more than 90 % of analysed drugs passing quality control tests in the laboratory. Tanzania Medicines and Medical Devices Authority (TMDA) undertook a special pharmaceuticals inspection on the market in 2019/20 in collaboration with other government organs. Some medications were removed from the market as a result of this inspection because they were counterfeit or substandard. Several counterfeit pharmaceuticals were found and removed from the market including Gentrisone cream 10 g, Cold cap Capsules, Sonaderm cream, Novidam (Homidium chloride) Tablets, Trypamidium samorin, Chloroquine Phosphate 250 mg, Sulphadoxine/Pyrimethamine and Sulfamethoxazole 400 mg/Tri-methoprim 80 mg. Appropriate pictures are seen in the paper: https://www.sciencedirect.com/science/article/pii/S2665910722000482

« back